AMF Tjänstepension’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $156M | Buy |
314,765
+1,848
| +0.6% | +$819K | 0.93% | 28 |
|
|
2026
Q1 | $140M | Buy |
312,917
+166,968
| +114% | +$77.9M | 0.93% | 28 |
|
|
2025
Q4 | $66.2M | Buy |
145,949
+83,487
| +134% | +$36M | 0.41% | 52 |
|
|
2025
Q3 | $24.5M | Sell |
62,462
-2,243
| -3% | -$937K | 0.16% | 87 |
|
|
2025
Q2 | $28.8M | Buy |
64,705
+3,710
| +6% | +$1.71M | 0.19% | 75 |
|
|
2025
Q1 | $29.6M | Sell |
60,995
-6,762
| -10% | -$3.15M | 0.22% | 71 |
|
|
2024
Q4 | $27.3M | Sell |
67,757
-100,161
| -60% | -$46.4M | 0.19% | 66 |
|
|
2024
Q3 | $78.1M | Sell |
167,918
-381,782
| -69% | -$183M | 0.56% | 35 |
|
|
2024
Q2 | $258M | Buy |
+549,700
| New | +$239M | 1.92% | 15 |
|
|
2023
Q4 | – | Sell |
-18,890
| Closed | -$6.57M | – | 221 |
|
|
2023
Q3 | $6.57M | Sell |
18,890
-33,839
| -64% | -$11.8M | 0.06% | 175 |
|
|
2023
Q2 | $18.6M | Sell |
52,729
-70,242
| -57% | -$23.7M | 0.17% | 102 |
|
|
2023
Q1 | $38.7M | Sell |
122,971
-604
| -0.5% | -$181K | 0.4% | 60 |
|
|
2022
Q4 | $35.7M | Buy |
123,575
+34,879
| +39% | +$10.6M | 0.41% | 58 |
|
|
2022
Q3 | $25.7M | Sell |
88,696
-3,842
| -4% | -$1.11M | 0.3% | 71 |
|
|
2022
Q2 | $26.1M | Sell |
92,538
-32,259
| -26% | -$8.63M | 0.26% | 73 |
|
|
2022
Q1 | $32.6M | Sell |
124,797
-1,120
| -0.9% | -$266K | 0.24% | 84 |
|
|
2021
Q4 | $27.7M | Sell |
125,917
-16,532
| -12% | -$3.21M | 0.19% | 105 |
|
|
2021
Q3 | $25.8M | Sell |
142,449
-13,034
| -8% | -$2.54M | 0.19% | 115 |
|
|
2021
Q2 | $31.4M | Sell |
155,483
-16,953
| -10% | -$3.55M | 0.22% | 99 |
|
|
2021
Q1 | $37.1M | Sell |
172,436
-800
| -0.5% | -$176K | 0.28% | 80 |
|
|
2020
Q4 | $40.9M | Sell |
173,236
-201,538
| -54% | -$46.2M | 0.33% | 72 |
|
|
2020
Q3 | $102M | Buy |
374,774
+33,058
| +10% | +$9.12M | 0.93% | 29 |
|
|
2020
Q2 | $99.2M | Buy |
341,716
+10,631
| +3% | +$2.88M | 1.02% | 25 |
|
|
2020
Q1 | $78.8M | Buy |
331,085
+157,054
| +90% | +$36M | 1% | 26 |
|
|
2019
Q4 | $38.1M | Buy |
174,031
+6,744
| +4% | +$1.36M | 0.36% | 70 |
|
|
2019
Q3 | $28.3M | Sell |
167,287
-385,014
| -70% | -$68.1M | 0.29% | 102 |
|
|
2019
Q2 | $101M | Sell |
552,301
-174,881
| -24% | -$30.6M | 0.98% | 19 |
|
|
2019
Q1 | $134M | Buy |
727,182
+290,570
| +67% | +$53.7M | 1.33% | 16 |
|
|
2018
Q4 | $72.4M | Buy |
436,612
+15,699
| +4% | +$2.72M | 0.79% | 30 |
|
|
2018
Q3 | $81.1M | Buy |
420,913
+129,587
| +44% | +$23.1M | 0.74% | 40 |
|
|
2018
Q2 | $49.5M | Sell |
291,326
-21,047
| -7% | -$3.26M | 0.48% | 74 |
|
|
2018
Q1 | $50.9M | Sell |
312,373
-7,776
| -2% | -$1.27M | 0.53% | 75 |
|
|
2017
Q4 | $48M | Buy |
320,149
+13,819
| +5% | +$2.05M | 0.47% | 85 |
|
|
2017
Q3 | $46.6M | Sell |
306,330
-6,354
| -2% | -$956K | 0.51% | 79 |
|
|
2017
Q2 | $34.2M | Hold |
312,684
| – | – | 0.39% | 102 |
|
|
2017
Q1 | $34.2M | Buy |
312,684
+12,243
| +4% | +$1.08M | 0.39% | 102 |
|
|
2016
Q4 | $22.1M | Buy |
+300,441
| New | +$24.4M | 0.26% | 131 |
|
Other funds holding VRTX
AMF Tjänstepension's VRTX Position: Q2 2026 in Review
AMF Tjänstepension increased its Vertex Pharmaceuticals (VRTX) stake by 0.59% in Q2 2026, buying an estimated $819K and bringing the position to 314,765 shares worth $156M. The position accounts for 0.93% of the portfolio, ranked #28.
AMF Tjänstepension first reported a position in VRTX in Q4 2016 and has held it in 37 quarters since. The position peaked at $258M in Q2 2024. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- AMF Tjänstepension held 314,765 shares of Vertex Pharmaceuticals worth $156M as of Q2 2026.
- AMF Tjänstepension bought 1,848 Vertex Pharmaceuticals shares in Q2 2026, an estimated $819K.
- Vertex Pharmaceuticals made up 0.93% of AMF Tjänstepension's portfolio in Q2 2026, its #28 holding.
- AMF Tjänstepension first reported a position in Vertex Pharmaceuticals in Q4 2016 and has held it in 37 quarters since.
- AMF Tjänstepension's Vertex Pharmaceuticals position peaked at $258M in Q2 2024.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on AMF Tjänstepension's 13F filing for Q2 2026, filed 6 Aug 2026.